Endonovo Therapeutics Inc (ENDV)

[3DYOGI]

The highbrowed investors are accumulating all they can between here and .20



Financing deal is in place.


World Renown Scientist conducted this study and is being groomed to take over the company.


Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical for Treatment of Kidney Disease

Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical for Treatment of Non-Alcoholic Steatohepatitis (NASH)

Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical Device for Treatment of Critical Limb Ischemia


Up List to Nasdaq in 2018.


Multi Billion Dollar potential by 2020


Updates on The Company's Cytotronics™ platform are coming harnesses the bulk electrical properties of cells and tissues, namely magnetically-induced electrical field pathways to expand and enhance the therapeutic potential of cell therapies and produce next-generation biologics.


$ENDV